Fujiwara, Y., Kato, S., Nishizaki, D., Miyashita, H., Lee, S., Nesline, M. K., Conroy, J. M., DePietro, P., Pabla, S., Ikeda, S., Kurzrock, R. (2025). Tumor mutational burden, PD-1, negative Wnt/β-catenin regulators, and positive MHC class II antigen presentation regulators as predictors of longer survival after immune checkpoint inhibitors across cancers: A comprehensive analysis of 400 immunity biomarkers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2625